# Amneal (AMRX) — Analyst Forecast

AMRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/amrx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $20.00 | $23.40 | $27.00 | 5 |

Last price $19.25 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 23, 2026 | Oppenheimer | Initiated Coverage | Outperform | $27.00 |
| Sep 17, 2026 | Barclays | Maintained | Overweight | $20.00 |
| Sep 9, 2026 | Leerink Partners | Initiated Coverage | Outperform | $23.00 |
| Aug 26, 2026 | JP Morgan | Maintained | Overweight | $22.00 |
| Aug 3, 2026 | UBS | Maintained | Buy | $25.00 |
| Jul 15, 2026 | UBS | Maintained | Buy | $23.00 |
| May 20, 2026 | Barclays | Maintained | Overweight | $16.00 |
| Apr 17, 2026 | UBS | Initiated Coverage | Buy | $19.00 |
| Mar 2, 2026 | Truist Securities | Maintained | Buy | $17.00 |
| Dec 9, 2025 | Barclays | Initiated Coverage | Overweight | $15.00 |
| Oct 31, 2025 | Piper Sandler | Maintained | Overweight | $13.00 |
| Sep 16, 2025 | JP Morgan | Maintained | Overweight | $14.00 |
| Mar 3, 2025 | Barclays | Maintained | Overweight | $11.00 |
| Feb 24, 2025 | JP Morgan | Upgraded | Neutral → Overweight | $12.00 |
| Nov 11, 2024 | Piper Sandler | Maintained | Overweight | $11.00 |
| Oct 2, 2024 | Truist Securities | Maintained | Buy | $12.00 |
| Sep 6, 2024 | JP Morgan | Upgraded | Underweight → Neutral | $9.00 |
| Aug 13, 2024 | Barclays | Maintained | Overweight | $10.00 |
| Aug 12, 2024 | Truist Securities | Maintained | Buy | $10.00 |
| May 6, 2024 | Truist Securities | Maintained | Buy | $9.00 |

## Frequently Asked Questions

### What is the price target for AMRX stock?

The average 12-month analyst price target for Amneal (AMRX) is $23.40, with a high estimate of $27.00 and a low of $20.00, across 5 analysts.

### Is AMRX a buy, sell, or hold?

Analysts covering Amneal currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for AMRX?

The average price target of $23.40 implies 21.56% upside from the last price of $19.25.

### What is the latest analyst rating on AMRX?

On Sep 23, 2026, Oppenheimer initiated coverage of Amneal at Outperform with a price target of $27.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).